Grace Therapeutics Inc (GRCE)
3.125
+0.02
(+0.81%)
USD |
NASDAQ |
Oct 31, 16:00
3.15
+0.02
(+0.80%)
After-Hours: 20:00
Grace Therapeutics Price to Book Value: 0.5380 for Oct. 31, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 30, 2024 | 0.5295 |
| October 29, 2024 | 0.5534 |
| October 28, 2024 | 0.5483 |
| October 25, 2024 | 0.5756 |
| October 24, 2024 | 0.5808 |
| October 23, 2024 | 0.6149 |
| October 22, 2024 | 0.562 |
| October 21, 2024 | 0.55 |
| October 18, 2024 | 0.5688 |
| October 17, 2024 | 0.5605 |
| October 16, 2024 | 0.5722 |
| October 15, 2024 | 0.579 |
| October 14, 2024 | 0.5585 |
| October 11, 2024 | 0.5706 |
| October 10, 2024 | 0.5825 |
| October 09, 2024 | 0.5654 |
| October 08, 2024 | 0.5158 |
| October 07, 2024 | 0.5312 |
| October 04, 2024 | 0.5312 |
| October 03, 2024 | 0.5124 |
| October 02, 2024 | 0.521 |
| October 01, 2024 | 0.5141 |
| September 30, 2024 | 0.5124 |
| September 27, 2024 | 0.5329 |
| September 26, 2024 | 0.5244 |
| Date | Value |
|---|---|
| September 25, 2024 | 0.5227 |
| September 24, 2024 | 0.4373 |
| September 23, 2024 | 0.4441 |
| September 20, 2024 | 0.4578 |
| September 19, 2024 | 0.4748 |
| September 18, 2024 | 0.4646 |
| September 17, 2024 | 0.4663 |
| September 16, 2024 | 0.4398 |
| September 13, 2024 | 0.3912 |
| September 12, 2024 | 0.3631 |
| September 11, 2024 | 0.3963 |
| September 10, 2024 | 0.4074 |
| September 09, 2024 | 0.4185 |
| September 06, 2024 | 0.4116 |
| September 05, 2024 | 0.4185 |
| September 04, 2024 | 0.427 |
| September 03, 2024 | 0.4364 |
| August 30, 2024 | 0.4475 |
| August 29, 2024 | 0.4509 |
| August 28, 2024 | 0.4321 |
| August 27, 2024 | 0.4236 |
| August 26, 2024 | 0.404 |
| August 23, 2024 | 0.4185 |
| August 22, 2024 | 0.41 |
| August 21, 2024 | 0.4202 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.1531
Minimum
Dec 12 2022
8.376
Maximum
Feb 10 2021
1.370
Average
0.4665
Median
Price to Book Value Benchmarks
| Aurinia Pharmaceuticals Inc | 2.832 |
| Edesa Biotech Inc | 3.738 |
| Lexaria Bioscience Corp | 3.405 |
| Xenon Pharmaceuticals Inc | 3.690 |
| ESSA Pharma Inc | 1.790 |
Price to Book Value Related Metrics
| Price | 3.125 |
| Earnings Yield | -45.23% |
| Market Cap | 31.69M |